Kyntra Bio, Inc.

Kyntra Bio, Inc.

KYNB ·

Kyntra Bio, Inc. (KYNB) is a Medical pharmaceuticals company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Kyntra Bio, Inc. in 2026. The next earnings report is expected on November 9, 2026.

Earnings calendar

Next earnings date

09 Nov 2026

In 82 days

EPS estimate

-3.66

Revenue estimate

2.0M

Past earnings

13 Aug 2026
EPS actual
2.96 (+193.0%)
estimate -3.18
Revenue actual
-1.5M (-171.8%)
estimate 2.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
11 May 2026
EPS actual
-3.76 (-12.1%)
estimate -3.36
Revenue actual
3.7M (+137.9%)
estimate 1.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
16 Mar 2026
EPS actual
-3.51 (+9.7%)
estimate -3.89
Revenue actual
1.3M (-22.2%)
estimate 1.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
10 Nov 2025
EPS actual
49.61 (+1,338.1%)
estimate -4.01
Revenue actual
1.1M (-55.8%)
estimate 2.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Kyntra Bio, Inc. beat EPS estimates but missed revenue expectations in its latest earnings, with EPS of $2.96 versus an estimate of -$3.1842 and revenue of -$1.5 million that fell 171.8% short of the $2.09 million expected. In the prior quarter, EPS fell short of expectations while revenue came in ahead of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Kyntra Bio, Inc. is a biopharmaceutical enterprise focused on the entire spectrum of therapeutic innovation, from discovering new compounds to developing and commercializing them. Leveraging profound insights into hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology, the company strives to engineer effective medicinal solutions for anemia, fibrotic conditions, and various forms of cancer. Founded by Thomas B. Neff on September 29, 1993, Kyntra Bio, Inc. maintains its corporate headquarters in San Francisco, California.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
United States
Exchange
Nasdaq
CEO
Thane Wettig
Employees
34
IPO date
29 Jan 2018
ISIN
US31572Q8814
Website
kyntrabio.com

Frequently asked questions

When does Kyntra Bio, Inc. (KYNB) next report earnings?

Kyntra Bio, Inc. (KYNB) is scheduled to report earnings on November 9, 2026.

What was Kyntra Bio, Inc.'s most recent earnings date?

Kyntra Bio, Inc. (KYNB) last reported earnings on August 13, 2026.

Where is Kyntra Bio, Inc. stock listed?

Kyntra Bio, Inc. (KYNB) is listed on Nasdaq.